🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
At present, the main characteristics of the enrolled population in the clin...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05411276
Treatments Being Tested
This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05350917
Treatments Being Tested
Part 1: to assess the safety and tolerability of pyrotinib and to define th...
Status
Unknown
Location
University of California, Irvine School of Medicine
Start Date
2015-06
Trial ID
NCT02500199
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of pyrotinib co...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2019-11
Trial ID
NCT04152057
Treatments Being Tested
This study is a single-arm, single-center exploratory clinical study. Twent...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-01-05
Trial ID
NCT04929548
Treatments Being Tested
This clinical trial aim to evaluate the efficacy and safety of Pyrotinib in...
Status
Unknown
Location
Multiple Locations
Start Date
2019-04-30
Trial ID
NCT03919253
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Recruiting
Location
Department of GI Oncology, Peking University Cancer Hospital,
Start Date
2024-11-01
Trial ID
NCT06684600
Treatments Being Tested
Based on different HR status, we explored the efficacy and safety of Pyroti...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-05-20
Trial ID
NCT05328440
Treatments Being Tested
Objective: To explore the efficacy and safety of Pyrotinib, trastuzumab sub...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06483386
Treatments Being Tested